Simulated Screening Study for Breast Imaging
Simulated Screening Study of Combined Digital X-Ray, Ultrasound and Photoacoustic Breast Imaging
2 other identifiers
observational
41
1 country
1
Brief Summary
This is a pilot, simulated breast cancer screening study. The goal of the study is to explore these scanning modalities: 1\) Combined digital breast tomosynthesis(DBT)/dual-sides 3 dimensional-automated ultrasound(AUS) 2\. Explore the utility of photoacoustic imaging as an adjunct to digital breast tomosynthesis(DBT)/ultrasound(US)alone.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2012
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2012
CompletedFirst Submitted
Initial submission to the registry
December 6, 2012
CompletedFirst Posted
Study publicly available on registry
March 8, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 23, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 23, 2020
CompletedMay 21, 2020
May 1, 2020
7.4 years
December 6, 2012
May 19, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluation of new breast imaging devices
To determine if photoacoustic imaging is an adjunct to standard of care imaging with regards to quality of imaging. and ultrasound modalities and to determine if combining digital breast tomosynthesis and 3 dimensional automated ultrasound will result in a lower call-back ratio than imaging with digital breast tomosynthesis alone.
3 years
Secondary Outcomes (1)
Determining the ratio of "patient call backs"
5 years
Study Arms (1)
Imaging scans for breast cancer screening
To simulate the performance of the combination of three new breast imaging systems to digital mammography and hand-held ultrasound that are currently used to find and evaluate breast masses. These three different systems make images of the breast in several ways to find breast masses and to distinguish normal and abnormal masses. This may result in less unnecessary call-backs from mammography.
Interventions
Digital tomosynthesis mammogram uses a low radiation dose, taking x-ray pictures of the breast from many angles to make a 3D(dimensional)image. The participant will be seated and her breast positioned as in a normal mammogram, though with reduced pressure. The x-ray tube will move quickly above the breast to take the images. Then, an ultrasound scan will be done using gel on your breast to assist in acquiring quality imaging.
The participant will be seated in front of the laser device with the breast positioned on the laser device platform. Each subject will be given a laser protective eye mask/goggles to wear and will be instructed how to wear the mask/goggles during the scan. In addition pulse monitor leads may be placed on the participant's chest to allow the computer to record ultrasound blood flow in the breast. The low intensity laser light will be focused on the targeted area of the breast.
Eligibility Criteria
The study population includes women who have had a mammogram at University of Michigan within one year who have been referred to the study. Participants may have a breast mass, either benign or cancerous.
You may qualify if:
- Women with possible masses
- All women should have had mammograms at University of Michigan Health System within 1 year before this research study.
You may not qualify if:
- Women who are physically unable to tolerate the length of the scan.
- Women who are less than 30 years of age or older than 80 years of age
- Women who are pregnant or lactating
- Women whose mass is in an area of the breast which makes it difficult to see in the research scans
- Womens with a single diagnosis of mammographic calcifications
- Women who have had a breast cancer with lumpectomy
- Women who are prisoners
- Women who are students or staff of investigators
- Women who cannot give consent
- Women with mammograms classified as probably benign because of follow-up of a recent benign biopsy.
- Women with breast pain who have been categorized as BIRADS(Breast Imaging Reporting and Data System) category 0(incomplete) on their most recent mammograms.
- Males, because their breast tissue is not easily imaged and numbers of potential cases are too few.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Michiganlead
- National Institutes of Health (NIH)collaborator
- National Cancer Institute (NCI)collaborator
Study Sites (1)
University of Michigan Hospital
Ann Arbor, Michigan, 48109, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Paul L Carson, PhD
Univ. of Michigan
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 6, 2012
First Posted
March 8, 2013
Study Start
December 1, 2012
Primary Completion
April 23, 2020
Study Completion
April 23, 2020
Last Updated
May 21, 2020
Record last verified: 2020-05
Data Sharing
- IPD Sharing
- Will not share